Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,389,629 papers from all fields of science
Search
Sign In
Create Free Account
sulconazole
Known as:
1-(beta-(4''-chlorobenzylthio)-2'4'-dichlorophenethyl)imidazole
, 1-[2-[[(4-chlorophenyl)methyl]thio]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
, sulconazole [Chemical/Ingredient]
A topical imidazole derivative with broad-spectrum antifungal and antibacterial activity. Sulconazole is excreted in both the feces and urine.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
10 relations
Broader (2)
Antifungal Agents
Imidazoles
Azoles
Cutaneous Candidiasis
Hypersensitivity
Mycoses
Expand
Narrower (2)
Myk
Sulconazole nitrate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Amino acid chiral ionic liquids combined with hydroxypropyl-β-cyclodextrin for drug enantioseparation by capillary electrophoresis.
Sandra Salido-Fortuna
,
M. Greño
,
M. Castro-Puyana
,
M. Marina
Journal of Chromatography A
2019
Corpus ID: 198965177
2019
2019
Disruption of the NF-κB/IL-8 Signaling Axis by Sulconazole Inhibits Human Breast Cancer Stem Cell Formation
H. Choi
,
Ji-Hyang Kim
,
Su-Lim Kim
,
Dong-Sun Lee
Cells
2019
Corpus ID: 201829496
Breast cancer stem cells (BCSCs) are tumor-initiating cells that possess the capacity for self-renewal. Cancer stem cells (CSCs…
Expand
2019
2019
Fourfold Filtered Statistical/Computational Approach for the Identification of Imidazole Compounds as HO-1 Inhibitors from Natural Products
G. Floresta
,
E. Amata
,
+5 authors
A. Rescifina
Marine Drugs
2019
Corpus ID: 73432020
Over-regulation of Heme oxygenase 1 (HO-1) has been recently identified in many types of human cancer, and in these cases, poor…
Expand
2019
2019
Investigation of dextrin‐based synergistic system with chiral ionic liquids as additives for enantiomeric separation in capillary electrophoresis
Yanjie Zhang
,
Yingxiang Du
,
Tao Yu
,
Zijie Feng
,
Jiaquan Chen
Journal of Pharmaceutical and Biomedical Analysis
2019
Corpus ID: 53564537
Highly Cited
2014
Highly Cited
2014
Single-walled carbon nanotube-based polymer monoliths for the enantioselective nano-liquid chromatographic separation of racemic pharmaceuticals.
Marwa Ahmed
,
M. M. A. Yajadda
,
+4 authors
A. Ghanem
Journal of Chromatography A
2014
Corpus ID: 26054402
Highly Cited
2009
Highly Cited
2009
Enantioselective addition of thioacetic acid to nitroalkenes via N-sulfinyl urea organocatalysis.
K. Kimmel
,
MaryAnn T. Robak
,
J. Ellman
Journal of the American Chemical Society
2009
Corpus ID: 1973999
The highly enantioselective addition of thioacetic acid to nitroalkenes using a new sulfinyl urea organocatalyst is described…
Expand
2007
2007
Enantiomeric separation of several antimycotic azole drugs using supercritical fluid chromatography.
L. Toribio
,
M. D. del Nozal
,
J. Bernal
,
C. Alonso
,
J. Jiménez
Journal of Chromatography A
2007
Corpus ID: 22557609
Highly Cited
2004
Highly Cited
2004
In vitro susceptibility testing of dermatophytes: comparison of disk diffusion and reference broth dilution methods.
N. Karaca
,
A. Koç
Diagnostic microbiology and infectious disease
2004
Corpus ID: 24609504
Highly Cited
2001
Highly Cited
2001
Comparison of the chiral resolution of econazole, miconazole, and sulconazole by HPLC using normal-phase amylose CSPs
H. Aboul‐Enein
,
I. Ali
Fresenius' Journal of Analytical Chemistry
2001
Corpus ID: 30606575
Abstract Resolution of the enantiomers of (±)-econazole, (±)-miconazole, and (±)-sulconazole has been achieved on different…
Expand
Highly Cited
1984
Highly Cited
1984
Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133…
F. Odds
,
C. Webster
,
A. Abbott
Journal of Antimicrobial Chemotherapy
1984
Corpus ID: 27203959
Nine new antifungal agents were tested for their activity in vitro in terms of relative inhibition factors (RIFs) against 26…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required